International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14511648
Original Research Article
The Correlation Between Neutrophil Count and the Severity of Ischemic Stroke Based on National Institutes of Health Stroke Scale (NIHSS)
Published
Dec. 18, 2024
Abstract

Background: Leukocytosis is well known to be a significant indicator of inflammatory response and have predictive value on the functional outcome in ischemic stroke.Numerous studies have analyzed the correlation between leukocyte count and the severity of ischemic stroke based on National Institutes of Health Stroke Scale (NIHSS). However, studies specifically focused on neutrophil count are still limited. The aim of this study is to explore the correlation between neutrophil count and ischemic stroke severity evaluated using NIHSS.Method: This analytical observational study used cross-sectional design and purposive sampling, with a total sample of 27 ischemic stroke patients. The neutrophil count and NIHSS scorewere collected at admission and then analyzed using Spearman correlation test. Results: This research found a significant relationship between neutrophil count and ischemic stroke severity based on NIHSS, with a p-value of <0.001. The correlation coefficient is 0.858, indicating a linear and very strong correlation.Conclusion: There was a significant correlation between neutrophil count and the severity of ischemic stroke based on NIHSS score

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1781 Views
136 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved